Are you Dr. Dennis?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 93 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
4940 Eastern Ave
Johns Hopkins Bayview Medical Center
Baltimore, MD 21224Phone+1 410-550-9250Fax+1 410-550-5445
Summary
- Dr. Phillip Dennis, MD is an oncologist in Baltimore, Maryland. He is currently licensed to practice medicine in Maryland. He is affiliated with Johns Hopkins Bayview Medical Center and Johns Hopkins Hospital.
Education & Training
Johns Hopkins UniversityFellowship, Hematology and Medical Oncology, 1995 - 1998- Johns Hopkins UniversityResidency, Internal Medicine, 1992 - 1995
New York University School of MedicineClass of 1992
Certifications & Licensure
MD State Medical License 1995 - 2026
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013-2014
- Elected Member The American Society for Clinical Investigation, 2007
Clinical Trials
- Study of Metformin Plus Paclitaxel/Carboplatin/Bevacizumab in Patients With Adenocarcinoma. Start of enrollment: 2012 May 01
- Azacitidine and Entinostat Before Chemotherapy in Treating Patients With Advanced Non-small Cell Lung Cancer Start of enrollment: 2013 May 01
Publications & Presentations
PubMed
- 25 citationsDurvalumab After Concurrent Chemoradiotherapy in Elderly Patients With Unresectable Stage III Non-Small-Cell Lung Cancer (PACIFIC).Mark A. Socinski, Mustafa Ozguroglu, A. Villegas, Davey B. Daniel, David Vicente
Clinical Lung Cancer. 2021-06-12 - 2 citationsPatient-reported outcomes with durvalumab by PD-L1 expression and prior chemoradiotherapy-related variables in unresectable stage III non-small-cell lung cancerMarina Chiara Garassino, Luis Paz-Ares, Rina Hui, Corinne Faivre-Finn, Alex Spira
Future Oncology. 2021-02-15 - 6 citationsCombining Nelfinavir With Chloroquine Inhibits In Vivo Growth of Human Lung Cancer Xenograft TumorsJaclyn LoPiccolo, Shigeru Kawabata, Joell J. Gills, Phillip A. Dennis
In Vivo. 2021-01-01
Press Mentions
Post-Trial NSCLC Immunotherapy: Do Positive Vibes Linger On?September 13th, 2019
